Unknown

Dataset Information

0

Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury.


ABSTRACT: PURPOSE:Recent developments in the field of cell therapy have led to a renewed interest in treatment of acute kidney injury (AKI). However, the early death of transplanted mesenchymal stem cells (MSCs) in stressful microenvironment of a recipient tissue is a major problem with this kind of treatment. The objective of this study was to determine whether overexpression of a cytoprotective factor, nuclear factor erythroid-2 related factor 2 (Nrf2), in MSCs could protect rats against AKI. METHODS:The Nrf2 was overexpressed in MSCs by recombinant adenoviruses, and the MSCs were implanted to rats suffering from cisplatin-induced AKI. RESULTS:The obtained results showed that transplantation with the engineered MSCs ameliorates cisplatin-induced AKI. Morphologic features of the investigated kidneys showed that transplantation with the MSCs in which Nrf2 had been overexpressed significantly improved the complications of AKI. CONCLUSION:These findings suggested that the engineered MSCs might be a good candidate to be further evaluated in clinical trials. However, detailed studies must be performed to investigate the possible carcinogenic effect of Nrf2 overexpression.

SUBMITTER: Mohammadzadeh-Vardin M 

PROVIDER: S-EPMC4517083 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury.

Mohammadzadeh-Vardin Mohammad M   Habibi Roudkenar Mehryar M   Jahanian-Najafabadi Ali A  

Advanced pharmaceutical bulletin 20150601 2


<h4>Purpose</h4>Recent developments in the field of cell therapy have led to a renewed interest in treatment of acute kidney injury (AKI). However, the early death of transplanted mesenchymal stem cells (MSCs) in stressful microenvironment of a recipient tissue is a major problem with this kind of treatment. The objective of this study was to determine whether overexpression of a cytoprotective factor, nuclear factor erythroid-2 related factor 2 (Nrf2), in MSCs could protect rats against AKI.<h4  ...[more]

Similar Datasets

| S-EPMC6220224 | biostudies-literature
| S-EPMC8904278 | biostudies-literature
| S-EPMC11247789 | biostudies-literature
| S-EPMC5905231 | biostudies-literature
| S-EPMC3273558 | biostudies-literature
| S-EPMC8758548 | biostudies-literature
| S-EPMC6619398 | biostudies-literature
| S-EPMC8014389 | biostudies-literature
| S-EPMC7364853 | biostudies-literature
| S-EPMC5561049 | biostudies-literature